Clinical trials
Recruiting Fibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 13 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 5 |
| Mayo Clinic | 4 |
| GlaxoSmithKline | 3 |
| M.D. Anderson Cancer Center | 3 |
| University of California, San Francisco | 3 |
| 89bio, Inc. | 2 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Madrigal Pharmaceuticals, Inc. | 2 |
| Pulmovant, Inc. | 2 |
| The Cleveland Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 64 |
| Non-alcoholic Fatty Liver Disease | 10 |
| Liver Cirrhosis | 8 |
| Liver Diseases | 8 |
| Fatty Liver | 7 |
| Carcinoma, Hepatocellular | 5 |
| Lung Diseases, Interstitial | 5 |
| Ascites | 4 |
| End Stage Liver Disease | 4 |
| Hypertension, Portal | 3 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.